$NUVB – Major Breakout! Watching for Continuation Toward $10.45

NUVB just delivered one of its biggest breakout moves of the year — ripping from the mid-$3 range into the $7s in a single vertical expansion candle.

This move cleared months of consolidation and broke straight through multiple resistance layers, signaling a major shift in momentum. With volume spiking to near multi-year highs, NUVB is now setting up for potential continuation into the next structural targets above.

The chart now sits above all local supply zones — the first time since early 2022 — suggesting this breakout may have legs if bulls maintain control.

📊 Technical Overview

• 
  [] Support Levels: $5.35 → $4.75 → $4.05
  [] Resistance Levels: $7.15 (current) → $8.50 → $10.45 (multi-year high)
  [] Structure: Long-term base breakout after multi-year downtrend & accumulation
  [] Momentum: RSI extended but trending strongly; breakout volume highest in years
• Trend Bias: Ultra-bullish above $5.35

As long as NUVB holds above $5.35, this breakout remains valid. A controlled pullback or sideways consolidation would be healthy after such an aggressive extension move.

A measured-move extension points toward $8.50, with potential continuation into the $10.45 zone — the major pivot high from the prior cycle.

🧬 Sector & Fundamental Context

Nuvation Bio operates in the oncology biotech space — a sector known for explosive multi-day moves following catalysts, early-stage trial updates, or institutional rotation.

While NUVB has traded sideways for nearly two years, this breakout aligns with increasing volume patterns across small-cap biotech names such as SLS, TCRT, and VCNX — suggesting early-phase capital rotation is returning to the sector.

Biotech breakouts of this scale often move in multi-wave sequences when supported by volume.

💡 My Plan

• 
  [] Entry Zone: Ideally on a pullback toward $5.80–$6.25
  [] Targets: $8.50 → $10.45
  [] Stretch Target: $11.00+ if volume remains elevated
  [] Invalidation: Close below $4.75 = failed breakout + reversion to range

Look for declining-volume pullbacks or flag formations to confirm continuation. Higher lows on the 4H/1D will signal readiness for a second expansion leg.

NUVB just printed one of the cleanest biotech breakouts on the market 🚀

Do you think it continues toward $10 — or does it need a deeper pullback first?

Drop your thoughts ⬇️
I’ll post the next MyMI continuation update if the $8.50 level breaks 📈
XBI TCRT SLS VCNX